Close

Analyst Ratings for Lexicon Pharmaceuticals (LXRX) [Buys]

LXRX Rating Summary

LXRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LXRX
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $3.50 (+41.1%) * Over Last 12-Mos
Rating Score: 2.5 / 10   Percentile Rank: 20%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/12/2022 Piper Sandler Yasmeen Rahimi New Coverage Overweight
(N/A)
10.00
(N/A)
2.78
(2.48)
-10.79% Details
12/8/2020 Citi
» Updated 12/12/2023
Yigal Nochomovitz Upgrade Buy
(Neutral)
4.00
(5.00)
1.58
(2.48)
56.96% Details
Like LXRX Ratings? Also take a look at CI, U, JNPR, GLW

LXRX Ratings News